Understanding Your Eye Stroke: Central Retinal Artery Occlusion (CRAO)
At a Glance
A Central Retinal Artery Occlusion (CRAO), or eye stroke, is a medical emergency caused by a blocked artery in the retina, leading to sudden, painless vision loss. Immediate medical care within 90 minutes to 4.5 hours is critical to restore blood flow and preserve remaining vision.
Sudden vision loss is an alarming medical emergency, but understanding what is happening is the first step toward protecting your health and vision. If you have been told you have a Central Retinal Artery Occlusion (CRAO), it is helpful to think of it as an “eye stroke” [1]. Just as a stroke in the brain occurs when blood flow is blocked, a CRAO happens when the main artery supplying blood to your retina—the light-sensitive tissue at the back of your eye—becomes obstructed [1][2]. This blockage starves the retina of the oxygen and nutrients it needs to function, leading to a sudden, usually painless, loss of vision [1].
Why the Term “Eye Stroke” is Used
Doctors use the term “eye stroke” because the biological process behind CRAO is nearly identical to a typical brain stroke [1][3].
- Embolism: A small clot or piece of plaque travels from elsewhere in the body (like the carotid artery in the neck or the heart) and gets stuck in the narrow retinal artery [1][4].
- Thrombosis: A clot forms directly inside the retinal artery, often due to damage or inflammation of the blood vessel walls [1][5].
- Systemic Connection: Because the eye is connected to the rest of your vascular system, a CRAO is often a signal of underlying health issues, such as high blood pressure, atrial fibrillation (an irregular heart rhythm), or carotid artery disease [6][7].
The Rare Nature of CRAO
If it feels like your medical team is moving with intense urgency, or if you have encountered doctors who have rarely seen this condition, it is because CRAO is relatively uncommon. Studies suggest that only about 2 to 6 people out of every 100,000 will experience a CRAO in a given year [8][9]. The incidence increases as people age, with the highest risk usually seen in those over the age of 80 [9]. Because it is a rare emergency, specialized protocols are often required to manage it effectively [10].
The Critical Window for Intervention
The urgency you may have felt from your care team is based on the extreme sensitivity of retinal tissue to a lack of oxygen (ischemia).
- The 90–240 Minute Window: Traditional research, much of it based on animal models, suggests that the retina can suffer irreversible damage if blood flow is not restored within 90 to 240 minutes [11].
- Modern Perspectives: While this narrow window is a standard benchmark for urgency, some human studies suggest that certain treatments, like intravenous thrombolysis (clot-dissolving medication), might still be beneficial if administered within 4.5 hours of the start of symptoms [12].
- The Goal of Speed: Every minute counts because the sooner the retina receives oxygen again—either through the body naturally clearing the clot or through medical intervention—the better the chance of preserving some level of vision [10][13].
Stabilizing Facts
While this diagnosis is serious, understanding the following can help you navigate the next steps:
- Don’t Blame Yourself if You Missed the Window: When vision loss is painless, many people wait to see if it gets better, and the guilt of waiting is heavy. The sudden nature of CRAO means that the “window” often begins before you even reach a doctor. The focus now is on protecting your remaining vision and identifying the cause to prevent future issues [6].
- Comprehensive Care is Essential: Because CRAO is linked to your heart and blood vessels, your “eye” problem will likely involve a team of doctors, including neurologists and cardiologists, to ensure your overall vascular health is stable [6][4].
- New Treatments are Evolving: While CRAO has historically been difficult to treat, modern medicine is increasingly applying stroke-level interventions—such as hyperbaric oxygen therapy and clot-dissolving drugs—to improve outcomes for patients caught early enough [3][12].
Common questions in this guide
What causes an eye stroke (CRAO)?
How quickly do I need treatment for an eye stroke?
Why do I need to see a cardiologist or neurologist for an eye problem?
What happens if I missed the initial treatment window for my eye stroke?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was the likely cause of my CRAO—was it a clot from my heart, my neck, or an inflammatory issue?
- 2.Does my imaging, like OCT, show significant retinal thickening or whitening?
- 3.Am I still within the window for treatments like intravenous thrombolysis or hyperbaric oxygen therapy?
- 4.What specific tests will be done to check my risk for a future stroke or heart attack?
- 5.Should I be screened for Giant Cell Arteritis, and what symptoms should I watch for?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
A review of the management of central retinal artery occlusion.
Madike R, Cugati S, Chen C
Taiwan journal of ophthalmology 2022; (12(3)):273-281 doi:10.4103/2211-5056.353126.
PMID: 36248088 - 2
Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): Study protocol of a phase III trial.
Poli S, Grohmann C, Wenzel DA, et al.
International journal of stroke : official journal of the International Stroke Society 2024; (19(7)):823-829 doi:10.1177/17474930241248516.
PMID: 38591748 - 3
CASE SERIES OF HYPERBARIC OXYGEN THERAPY FOR CENTRAL RETINAL ARTERY OCCLUSION.
Masters TC, Westgard BC, Hendriksen SM, et al.
Retinal cases & brief reports 2021; (15(6)):783-788 doi:10.1097/ICB.0000000000000895.
PMID: 31306292 - 4
SUDDEN VISION LOSS FROM CENTRAL RETINAL ARTERY OCCLUSION AS A PRESENTING SYMPTOM OF MITRAL VALVE PAPILLARY FIBROELASTOMA.
Henao M, Chamchikh J, Chalam KV
Retinal cases & brief reports 2022; (16(1)):95-98 doi:10.1097/ICB.0000000000000915.
PMID: 31574007 - 5
Choroidal ischemia as one cardinal sign in giant cell arteritis.
Casella AMB, Mansour AM, Ec S, et al.
International journal of retina and vitreous 2022; (8(1)):69 doi:10.1186/s40942-022-00422-z.
PMID: 36153565 - 6
Stroke Risk Before and After Central Retinal Artery Occlusion in a US Cohort.
Chodnicki KD, Pulido JS, Hodge DO, et al.
Mayo Clinic proceedings 2019; (94(2)):236-241 doi:10.1016/j.mayocp.2018.10.018.
PMID: 30711121 - 7
The role of triglyceride-glucose index in central retinal artery occlusion.
Sirakaya HA, Ayyildiz B, Sert II, et al.
International ophthalmology 2025; (45(1)):82 doi:10.1007/s10792-024-03344-x.
PMID: 39998764 - 8
Nationwide incidence of central retinal artery occlusion in Japan: an exploratory descriptive study using the National Database of Health Insurance Claims (2011-2015).
Kido A, Tamura H, Ikeda HO, et al.
BMJ open 2020; (10(9)):e041104 doi:10.1136/bmjopen-2020-041104.
PMID: 32973068 - 9
Assessment of Trends in the Incidence Rates of Central Retinal Artery Occlusion in Korea From 2002 to 2015.
Kim J, Byun SJ, Woo SJ, et al.
JAMA ophthalmology 2021; (139(4)):399-405 doi:10.1001/jamaophthalmol.2020.6860.
PMID: 33570556 - 10
Eye stroke protocol in in the emergency department.
Bénard-Séguin É, Nahab F, Pendley AM, et al.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2024; (33(9)):107895 doi:10.1016/j.jstrokecerebrovasdis.2024.107895.
PMID: 39079617 - 11
Central retinal artery occlusion - rethinking retinal survival time.
Tobalem S, Schutz JS, Chronopoulos A
BMC ophthalmology 2018; (18(1)):101 doi:10.1186/s12886-018-0768-4.
PMID: 29669523 - 12
Intravenous Fibrinolysis for Central Retinal Artery Occlusion: A Cohort Study and Updated Patient-Level Meta-Analysis.
Mac Grory B, Nackenoff A, Poli S, et al.
Stroke 2020; (51(7)):2018-2025 doi:10.1161/STROKEAHA.119.028743.
PMID: 32568646 - 13
Artificial Intelligence-Based Detection of Central Retinal Artery Occlusion Within 4.5 Hours on Standard Fundus Photographs.
Gungor A, Sarbout I, Gilbert AL, et al.
Journal of the American Heart Association 2025; (14(13)):e041441 doi:10.1161/JAHA.124.041441.
PMID: 40576025
This page provides educational information about Central Retinal Artery Occlusion (CRAO). Because it is a medical emergency, seek immediate emergency care for sudden vision loss; this content does not replace professional medical advice.
Get notified when new evidence is published on Central retinal artery occlusion.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.